{
  "id": 15781376,
  "title": "New ICER report suggests drug launch prices are outpacing their worth",
  "url": "https://urgent.news/2026/10/20/new-icer-report-suggests-drug-launch-prices-are-outpacing-their-worth",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-20T17:57:40.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/new-icer-report-suggests-drug-launch-prices-are-outpacing-their-worth/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The median list price of drugs at launch rose 24% from 2022 to 2025, and the net prices of those drugs rose even higher, according to a new report from the Institute for Clinical and ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Most new drugs are still too costly at launch, ICER says",
        "url": "https://urgent.news/2026/10/20/most-new-drugs-are-still-too-costly-at-launch-icer-says",
        "published": "2026-10-20T15:55:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}